One of the best investors riding the artificial intelligence (AI) revolution is Stanley Druckenmiller at the Duquesne Family ...

Last month's fiscal second quarter was a perfect example of Nvidia stock perpetually scaling the wall of worry. Bears were ...

Shares of IonQ ( IONQ +7.83%) are soaring today. The quantum computing stock is up 8.1% as of 10:50 a.m. ET, having surged as ...

Pfizer spent $7 billion in 2025 to acquire Metsera, adding late-stage weight-loss therapies to its portfolio. Pfizer's last ...

If you don't panic and keep the bigger, longer-term picture in mind, these setbacks are actually opportunities.

A stock that just hit a 52-week low doesn't usually need much to bounce. NuScale Power ( SMR +15.00%) found that out in ...

In quick succession, first Oppenheimer analyst Brian Schwartz estimated Oracle stock is worth $275 a share, then Mizuho ...

GLP-1 weight-loss drugs burst onto the scene when Novo Nordisk (NVO-2.76%) introduced Wegovy to the world. There was so much ...

On the heels of this news, Northland Securities analyst Gus Richard upgraded Intel to outperform (buy), from market perform ...

Alphabet's stock has some goofy things going on with its valuation metrics.

Meanwhile, Lockheed Martin stock costs barely 19.2 times earning -- and less than 14 times free cash flow. Weighed against ...

Oracle has underperformed the tech sector over the past year, but its fortunes can turnaround thanks to a robust revenue ...